Homes and Property | Home PageCopycat threat to Glaxosmithkline13 April 2012GLAXOSMITHKLINE'S Wellbutrin anti-depressant faces a generic competitor. America's Eon Labs got approval for a copycat version. Wellbutrin's ninemonth sales were £726m, mostly in the US.